Skip to content

Laboratory Corporation of America Holdings Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 28, 2026 results vs estimates

Laboratory Corporation of America Holdings · E.LH.NYSE · United States
Use symbol E.LH.NYSE in our API & Excel add-in to retrieve this data ↓
368.16
(+0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 33.79%

Laboratory Corporation of America Holdings Forecast

Laboratory Corporation of America Holdings short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 33.8% a year, a typical one-standard-deviation range is 350.64–385.68 over a week, 332.25–404.07 over a month and 243.75–492.57 over a year. (Signals as of 1 Nov 2026.)

Laboratory Corporation of America Holdings Price Chart

MacroFinance.ai

Laboratory Corporation of America Holdings Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Laboratory Corporation of America Holdings
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Laboratory Corporation of America Holdings
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Laboratory Corporation of America Holdings
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Laboratory Corporation of America Holdings
P/E
29.92x
Mid-range vs own history
QoQ +8.7%
YoY +15.1%
now 29.922222.05 low30.11 high
ⓘP/E As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Laboratory Corporation of America Holdings
P/S
2.06x
Stretched vs own history
QoQ +7.1%
YoY +27.4%
now 2.05841.47 low2.07 high
ⓘP/S As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Laboratory Corporation of America Holdings
P/B
3.40x
Stretched vs own history
QoQ +6.0%
YoY +32.8%
now 3.39542.38 low3.42 high
ⓘP/B As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Laboratory Corporation of America Holdings
EV/EBITDA
16.94x
Stretched vs own history
QoQ +6.6%
YoY +18.1%
now 16.942113.1 low17.03 high
ⓘEV/EBITDA As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Laboratory Corporation of America Holdings
EV/Sales
2.50x
Stretched vs own history
QoQ +5.1%
YoY +19.5%
now 2.50481.91 low2.52 high
ⓘEV/Sales As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Laboratory Corporation of America Holdings
FCF Yield
4.3%
Weak vs own history
QoQ +2.3%
YoY −31.0%
now 4.28374.19 low6.67 high
ⓘFCF Yield As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Laboratory Corporation of America Holdings
Earnings Yield
3.3%
Mid-range vs own history
QoQ −8.0%
YoY −13.1%
now 3.3423.32 low4.54 high
ⓘEarnings Yield As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Laboratory Corporation of America Holdings
Dividend Yield
0.8%
Weak vs own history
QoQ −8.9%
YoY −27.2%
now 0.79020.79 low1.16 high
ⓘDividend Yield As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Laboratory Corporation of America Holdings
Market Cap
$30.0B
Highest in 5 years
QoQ +8.9%
YoY +35.1%
now 30041.85620,758 low30,231 high
ⓘMarket Cap As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Laboratory Corporation of America Holdings
Net Debt
$6.5B
High vs own history
QoQ −1.7%
YoY −1.7%
now 6514.15,994 low6,624 high
ⓘNet Debt As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Laboratory Corporation of America Holdings
Net Debt / EBITDA
3.02x
Mid-range vs own history
QoQ −1.9%
YoY −8.3%
now 3.0192.98 low3.29 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Laboratory Corporation of America Holdings
Current Ratio
1.41x
Mid-range vs own history
QoQ −21.7%
YoY −9.3%
now 1.40671.41 low1.8 high
ⓘCurrent Ratio As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Laboratory Corporation of America Holdings
Quick Ratio
1.22x
Mid-range vs own history
QoQ −20.6%
YoY −10.1%
now 1.21571.22 low1.54 high
ⓘQuick Ratio As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Laboratory Corporation of America Holdings
Interest Coverage
6.29x
Mid-range vs own history
QoQ −1.7%
YoY +9.8%
now 6.29355.73 low6.41 high
ⓘInterest Coverage As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Laboratory Corporation of America Holdings
Debt / Equity
0.77x
Mid-range vs own history
QoQ −2.6%
YoY −7.8%
now 0.76580.76 low0.83 high
ⓘDebt / Equity As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Laboratory Corporation of America Holdings
Piotroski F-Score
8
Mid-range vs own history
QoQ 0.0%
YoY −11.1%
now 86 low9 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Laboratory Corporation of America Holdings
Altman Z-Score
3.55
Strong vs own history
QoQ +2.2%
YoY +12.5%
now 3.54712.95 low3.56 high
ⓘAltman Z-Score As of 22 Nov 2026.See Laboratory Corporation of America Holdings returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Laboratory Corporation of America Holdings, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Laboratory Corporation of America Holdings fundamentals: income statement, balance sheet & cash flow

Laboratory Corporation of America Holdings reported revenue of $13.95bn and net income of $876.5m in FY2025, the year ended 31 December 2025 — revenue up 7.2% and net income up 17.5% on the prior year. Free cash flow was $1.21bn. These figures are as reported in the filings, not restated: 38 fiscal years and 155 quarters of history, back to December 1988. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$13.95bn
+7.2%
Net income
$876.5m
+17.5%
Gross margin
28.76%
Free cash flow
$1.21bn
+10.0%
Net debt
$5.99bn
Shares short (30 Oct 2026)
2.54m
3.01 days to cover
Laboratory Corporation of America Holdings income statement, annual, as reported · USD billions unless stated
USD billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue13.9513.0112.1611.8613.14
Cost of revenue9.949.388.808.168.14
Gross profit4.013.623.363.714.99
Research & development——0.00——
Selling, general & admin.2.222.23—2.001.95
Operating income1.381.090.731.443.05
EBITDA2.011.811.351.953.68
Interest expense0.220.210.200.180.21
Pre-tax income1.110.960.571.242.89
Income tax0.230.210.190.230.69
Net income0.880.750.421.282.38

Download Laboratory Corporation of America Holdings fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.LH.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 38 fiscal years and 155 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Laboratory Corporation of America Holdings

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Laboratory Corporation of America Holdings Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Laboratory Corporation of America Holdings; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Laboratory Corporation of America Holdings’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Laboratory Corporation of America Holdings behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Laboratory Corporation of America Holdings (United States)

Laboratory Corporation of America Holdings is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Labcorp Holdings Inc.

Frequently asked questions

What is Laboratory Corporation of America Holdings?
Laboratory Corporation of America Holdings is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Laboratory Corporation of America Holdings price?
The latest close is 368.16 (1 Nov 2026), +0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Laboratory Corporation of America Holdings in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Laboratory Corporation of America Holdings?
20-day realised volatility is 33.8% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 9.8% over a month and 4.8% over a week.
What factors affect Laboratory Corporation of America Holdings?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Laboratory Corporation of America Holdings, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Laboratory Corporation of America Holdings?
58 backtested tactical asset allocation strategies trade Laboratory Corporation of America Holdings through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Laboratory Corporation of America Holdings returns analysed?
The Statistical Distribution of Returns section shows the distribution of Laboratory Corporation of America Holdings daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Laboratory Corporation of America Holdings historical data?
In the Free historical data section of this page: the last 10 years of Laboratory Corporation of America Holdings daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Laboratory Corporation of America Holdings historical data (last 10 years)

Browse or instantly download the last 10 years of Laboratory Corporation of America Holdings daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.LH.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20367.13
2026-11-19368.88
2026-11-18370.78
2026-11-17368.24
2026-11-16372.46
2026-11-13370.48
2026-11-12372.32
2026-11-11372.23
2026-11-10370.88
2026-11-09371.83
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics. The company was founded in 1995 and is headquartered in Burlington, North Carolina.